Literature DB >> 7110380

Binding of thioridazine and thioridazine metabolites to serum proteins. An in vitro study.

G Nyberg, E Mårtensson.   

Abstract

The binding constants of the binding between thioridazine and its metabolites, side-chain sulfoxide, side-chain sulfone and ring sulfoxide, on the one hand, and the plasma proteins, alpha 1-acid glycoprotein, albumin and total serum proteins, on the other, were determined. The binding constants between the drug substances and alpha 1-acid glycoprotein were found to be about a thousand times higher than the binding constants between the drug substances and albumin. The binding constants of whole serum were close to those of alpha 1-acid glycoprotein. Analysis of the binding data indicated competition between thioridazine and its metabolites. A number of drug substances were screened for possible binding interaction with thioridazine and its metabolites. Tricyclic antidepressants and propranolol significantly increased the free concentration of thioridazine. Also salicyclic acid and the plasticizing agent, TBEP, had this effect.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7110380     DOI: 10.1007/bf00495864

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  7 in total

1.  Plasma protein binding of basic drugs. II. Importance of alpha 1-acid glycoprotein for interindividual variation.

Authors:  K M Piafsky; O Borgå
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

2.  Drug-protein interactions: evaluation of the binding of antipsychotic drugs to glutamate dehydrogenase by quantitative affinity chromatography.

Authors:  F M Veronese; R Bevilacqua; I M Chaiken
Journal:  Mol Pharmacol       Date:  1979-03       Impact factor: 4.436

3.  Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients.

Authors:  G Nyberg; R Axelsson; E Mårtensson
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

Review 4.  Binding of drugs by albumin and plasma protein.

Authors:  J J Vallner
Journal:  J Pharm Sci       Date:  1977-04       Impact factor: 3.534

5.  Cerebrospinal fluid concentrations of thioridazine and its main metabolites in psychiatric patients.

Authors:  G Nyberg; R Axelsson; E Mårtensson
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

6.  Serum concentration and protein binding of thioridazine and its metabolites in patients with chronic alcoholism.

Authors:  R Axelsson; E Mårtensson; C Alling
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

7.  Plasma protein binding of basic drugs. I. Selective displacement from alpha 1-acid glycoprotein by tris(2-butoxyethyl) phosphate.

Authors:  O Borgå; K M Piafsky; O G Nilsen
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

  7 in total
  7 in total

1.  Selectivity in the binding of psychotropic drugs to the variants of alpha-1 acid glycoprotein.

Authors:  C B Eap; C Cuendet; P Baumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-02       Impact factor: 3.000

2.  Unbound plasma concentrations, total plasma concentrations, and red blood cell concentrations of thioridazine and its main metabolites: an in vitro study.

Authors:  G Nyberg; E Mårtensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

3.  Determination of free fractions of tricyclic antidepressants.

Authors:  G Nyberg; E Mårtensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

4.  Reduced emergence of isoniazid resistance with concurrent use of thioridazine against acute murine tuberculosis.

Authors:  Noton K Dutta; Michael L Pinn; Petros C Karakousis
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

5.  Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners.

Authors:  Sandirai Musuka; Shashikant Srivastava; Chandima Wasana Siyambalapitiyage Dona; Claudia Meek; Richard Leff; Jotam Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

6.  Thioridazine lacks bactericidal activity in an animal model of extracellular tuberculosis.

Authors:  Noton K Dutta; Michael L Pinn; Ming Zhao; Michelle A Rudek; Petros C Karakousis
Journal:  J Antimicrob Chemother       Date:  2013-03-05       Impact factor: 5.790

7.  Assessments of Thioridazine as a Helper Compound to Dicloxacillin against Methicillin-Resistant Staphylococcus aureus: In Vivo Trials in a Mouse Peritonitis Model.

Authors:  Michael Stenger; Kristoffer Hendel; Peter Bollen; Peter B Licht; Hans Jørn Kolmos; Janne K Klitgaard
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.